(Q50626015)

16 March 2018

title

What has virtual screening ever done for drug discovery? (English)

1 reference

16 March 2018

1 reference

1 reference

David E Clark

1

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 August 2008

1 reference

16 March 2018

Expert Opinion on Drug Discovery

published in

1 reference

16 March 2018

volume

3

1 reference

16 March 2018

issue

8

1 reference

16 March 2018

page(s)

841-851

1 reference

16 March 2018

What has computer-aided molecular design ever done for drug discovery?

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

A virtual screening approach applied to the search for trypanothione reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Virtual screening—an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Theoretical and practical considerations in virtual screening: a beaten field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Essential factors for successful virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Ligand docking and structure-based virtual screening in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Advances in virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Comparison of topological, shape, and docking methods in virtual screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Tolerability, pharmacokinetics, and neuroendocrine effects of PRX-00023, a novel 5-HT1A agonist, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

G protein-coupled receptors: in silico drug discovery in 3D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

PREDICT modeling and in-silico screening for G-protein coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Modeling the 3D structure of GPCRs from sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

ProPose: a docking engine based on a fully configurable protein-ligand interaction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

ProPose: steered virtual screening by simultaneous protein-ligand docking and ligand-ligand alignment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

SAR, species specificity, and cellular activity of cyclopentene dicarboxylic acid amides as DHODH inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Dual binding mode of a novel series of DHODH inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Scoring functions for protein-ligand docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Rapid estimation of relative protein-ligand binding affinities using a high-throughput version of MM-PBSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Finding more needles in the haystack: A simple and efficient method for improving high-throughput docking results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Incorporating protein flexibility into docking and structure-based drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Side-chain flexibility in protein-ligand binding: the minimal rotation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

FlexE: efficient molecular docking considering protein structure variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Protein flexibility in ligand docking and virtual screening to protein kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Novel procedure for modeling ligand/receptor induced fit effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Water at biomolecular binding interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Water mediation in protein folding and molecular recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Water, water everywhere--except where it matters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

WaterScore: a novel method for distinguishing between bound and displaceable water molecules in the crystal structure of the binding site of protein-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Classification of water molecules in protein binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Robust Classification of “Relevant” Water Molecules in Putative Protein Binding Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

A comparison of heuristic search algorithms for molecular docking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Modeling water molecules in protein-ligand docking using GOLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Application and limitations of X-ray crystallographic data in structure-based ligand and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Towards improving compound selection in structure-based virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

A comparison of field-based similarity searching methods: CatShape, FBSS, and ROCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Molecule-pharmacophore superpositioning and pattern matching in computational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

Comparison of Shape-Matching and Docking as Virtual Screening Tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.8.841

21 January 2018

Identifiers

DOI

10.1517/17460441.3.8.841

1 reference

16 March 2018

1 reference

16 March 2018